FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

447180001: Product containing precisely buprenorphine 10 microgram/1 hour prolonged-release transdermal patch (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
3764354011 Buprenorphine 10 microgram/hour prolonged-release transdermal patch en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)
3764355012 Product containing precisely buprenorphine 10 microgram/1 hour prolonged-release transdermal patch (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Buprenorphine 10 microgram/hour prolonged-release transdermal patch Is a Buprenorphine only product true Inferred relationship Some
Buprenorphine 10 microgram/hour prolonged-release transdermal patch Has manufactured dose form Prolonged-release transdermal patch (dose form) true Inferred relationship Some
Buprenorphine 10 microgram/hour prolonged-release transdermal patch Has basis of strength substance (attribute) Buprenorphine (substance) true Inferred relationship Some 1
Buprenorphine 10 microgram/hour prolonged-release transdermal patch Has concentration strength denominator unit hour true Inferred relationship Some 1
Buprenorphine 10 microgram/hour prolonged-release transdermal patch Has concentration strength numerator unit mcg true Inferred relationship Some 1
Buprenorphine 10 microgram/hour prolonged-release transdermal patch Has precise active ingredient Buprenorphine (substance) true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

International Patient Summary

Back to Start